|
Case
| HBS Case Collection
|
1997
BioTransplant, Inc.: Initial Public Offering, January 1996
by
Paul A. Gompers and Alexander Tsai
|
Abstract
Examines the decision to go public. BioTransplant is an early stage biotechnology company that must decide how to finance its research and development. The pros and cons of public offerings are analyzed versus alternative financing sources.
Keywords: Initial Public Offering;
Financing and Loans;
Research and Development;
Going Public;